P1-283: The effect of APOE genotype on brain levels of oxysterols in young and old human APOE ∊2, ∊3 and ∊4 knock-in mice

2010 ◽  
Vol 6 ◽  
pp. S255-S256
Author(s):  
Wei Ling Florence Lim ◽  
Andrew M. Jenner ◽  
Mary Pei Ern Ng ◽  
Markus R. Wenk ◽  
Guanghou Shui ◽  
...  
Neuroscience ◽  
2010 ◽  
Vol 169 (1) ◽  
pp. 109-115 ◽  
Author(s):  
A.M. Jenner ◽  
W.L.F. Lim ◽  
M.P.E. Ng ◽  
M.R. Wenk ◽  
G. Shui ◽  
...  

2013 ◽  
Vol 23 (5) ◽  
pp. 1365-1375 ◽  
Author(s):  
W. Zhao ◽  
S. B. Dumanis ◽  
I. Y. Tamboli ◽  
G. A. Rodriguez ◽  
M. Jo LaDu ◽  
...  

2021 ◽  
pp. 1-14
Author(s):  
Naazneen Khan ◽  
Yelena Alimova ◽  
Sophie J. Clark ◽  
Hemendra Vekaria ◽  
Adeline E. Walsh ◽  
...  

Background: Alzheimer’s disease (AD) is a progressive age-dependent disorder whose risk is affected by genetic factors. Better models for investigating early effects of risk factors such as apolipoprotein E (APOE) genotype are needed. Objective: To determine whether APOE genotype produces neuropathologies in an AD-susceptible neural system, we compared effects of human APOE ɛ3 (E3) and APOE ɛ4 (E4) alleles on the mouse olfactory epithelium. Methods: RNA-Seq using the STAR aligner and DESeq2, immunohistochemistry for activated caspase-3 and phosphorylated histone H3, glucose uptake after oral gavage of 2-[1,2-3H (N)]-deoxy-D-glucose, and Seahorse Mito Stress tests on dissociated olfactory mucosal cells. Results: E3 and E4 olfactory mucosae show 121 differentially abundant mRNAs at age 6 months. These do not indicate differences in cell type proportions, but effects on 17 odorant receptor mRNAs suggest small differences in tissue development. Ten oxidoreductases mRNAs important for cellular metabolism and mitochondria are less abundant in E4 olfactory mucosae but this does not translate into differences in cellular respiration. E4 olfactory mucosae show lower glucose uptake, characteristic of AD susceptibility and consistent with greater expression of the glucose-sensitive gene, Asns. Olfactory sensory neuron apoptosis is unaffected at age 6 months but is greater in E4 mice at 10 months. Conclusion: Effects of human APOE alleles on mouse olfactory epithelium phenotype are apparent in early adulthood, and neuronal loss begins to increase by middle age (10 months). The olfactory epithelium is an appropriate model for the ability of human APOE alleles to modulate age-dependent effects associated with the progression of AD.


1998 ◽  
Vol 18 (4) ◽  
pp. 361-366 ◽  
Author(s):  
Huaxin Sheng ◽  
Daniel T. Laskowitz ◽  
Ellen Bennett ◽  
Donald E. Schmechel ◽  
Robert D. Bart ◽  
...  

Apolipoprotein E (apoE), a 34-kD glycosylated lipid-binding protein, is expressed as three common isoforms in humans (E2, E3, or E4). Clinical evidence suggests that the apoE genotype (APOE) may be a risk factor for poor outcome after acute central nervous system injury. This was examined further in transgenic mice constructed with the human APOE3 or APOE4 gene under the control of human promoter and tissue expression elements. Presence of human apoE3 and apoE4 proteins in brains of human APOE homozygous transgenic mice was confirmed by Western blotting. APOE3 (n = 12) and APOE4 (n = 10) mice underwent 60 minutes of middle cerebral artery occlusion. After 24-hour recovery, infarct size was measured. Infarct volumes (mean ± standard deviation) were smaller in the APOE3 group (cortex: APOE3 = 18 ± 4 mm3; APOE4 = 30 ± 11 mm3, P = 0.04; subcortex: APOE3 = 12 ± 4 mm3; APOE4 = 18 ± 4 mm3, P = 0.003). Hemiparesis was less severe in APOE3 mice ( P = 0.02). These data indicate that human isoform-specific effects of apoE are relevant to acute pathomechanisms of focal ischemic brain damage when examined in the mouse. APOE transgenic mice may provide an appropriate model to examine the mechanistic basis for the differential effects of human apoE isoforms in acute central nervous system injury.


2019 ◽  
Vol 16 (4) ◽  
pp. 302-315 ◽  
Author(s):  
G. Peggy McFall ◽  
Lars Bäckman ◽  
Roger A. Dixon

Background: Apolipoprotein E (APOE) is a prominent genetic risk factor for Alzheimer’s disease (AD) and a frequent target for associations with non-demented and cognitively impaired aging. APOE offers a unique opportunity to evaluate two dichotomous comparisons and selected gradations of APOE risk. Some evidence suggests that APOE effects may differ by sex and emerge especially in interaction with other AD-related biomarkers (e.g., vascular health). Methods: Longitudinal trajectories of non-demented adults (n = 632, 67% female, Mage = 68.9) populated a 40-year band of aging. Focusing on memory performance and individualized memory trajectories, a sequence of latent growth models was tested for predictions of (moderation between) APOE and pulse pressure (PP) as stratified by sex. The analyses (1) established robust benchmark PP effects on memory trajectories, (2) compared predictions of alternative dichotomous groupings (ε4- vs ε4+, ε2- vs ε2+), and (3) examined precision-based predictions by disaggregated APOE genotypes. Results: Healthier (lower) PP was associated with better memory performance and less decline. Therefore, all subsequent analyses were conducted in the interactive context of PP effects and sex stratification. The ε4-based dichotomization produced no differential genetic predictions. The ε2-based analyses showed sex differences, including selective protection for ε2-positive females. Exploratory follow-up disaggregated APOE genotype analyses suggested selective ε2 protection effects for both homozygotic and heterozygotic females. Conclusion: Precision analyses of AD genetic risk will advance the understanding of underlying mechanisms and improve personalized implementation of interventions.


2017 ◽  
Vol 14 (9) ◽  
Author(s):  
Shaun Frost ◽  
Alauddin Bhuiyan ◽  
David Offerman ◽  
James D. Doecke ◽  
S. Lance Macaulay ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document